<DOC>
	<DOC>NCT02075554</DOC>
	<brief_summary>The primary objective of this study is to evaluate the safety and efficacy of CALIBER expandable spacer for the treatment of degenerative disc disease. Radiographic outcomes, intra-operative parameters, clinical outcomes, and patient satisfaction will be obtained from patients in this 2 year follow-up clinical study.</brief_summary>
	<brief_title>Efficacy and Safety of Expandable Spacer in the Treatment of Degenerative Disc Disease Using the Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach</brief_title>
	<detailed_description>Patients will be followed-up at 3weeks, 6 weeks, 3 months, 6 months, 12 and 24 months with X-rays and questionnaires to determine their satisfaction, healing, fusion and return to work status</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>DDD at 1 or 2 levels between L2 and S1 Between 18 and 80 years of age Unresponsiveness to documented nonsurgical treatment modalities for a minimum of six months Ability to provide a signed Informed Consent Trauma at level(s) to be fused Previous documentation of osteopenia, osteoporosis, or osteomalacia to a degree that spinal instrumentation would be contraindicated Immunosuppressive disorder History of substance abuse Any known allergy to a metal alloy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>